- Home
- » Tags
- » Lenograstim
Top View
- White Blood Cell Colony Stimulating Factors – Value & Balance Exchange Medical Benefit Drug Policy
- Horizon Scanning Status Report June 2020 Prepared For: Patient-Centered Outcomes Research Institute 1828 L St., NW, Suite 900 Washington, DC 20036
- (G-Csfs) (Filgrastim, Lenograstim, Lipegfilgrastim and Pegfilgrastim): New Warning Regarding Aortitis
- Lenograstim-Mobilized Peripheral Blood Progenitor Cells in Volunteer Donors: an Open Label Randomized Split Dose Escalating Study
- Hematopoietic Progenitor Cell Mobilization for Autologous Transplantation
- Granocyte Data Sheet
- Lonquex 6 Mg Solution for Injection in Pre-Filled Syringe
- Peripheral Blood Progenitor Cells Mobilization in Patients with Multiple Myeloma
- Systematic Review of Randomized Controlled Trials of Hematopoietic Stem Cell Mobilization Strategies for Autologous Transplantat
- Publication Only
- Targeting the FMS-Like Tyrosine Kinase 3 in Acute Myeloid Leukemia
- Human Granulocyte-Colony Stimulating Factor (G-CSF)/Stem Cell Factor (SCF) Fusion Proteins: Design, Characterization and Activity
- Haematological Malignancies
- How I Treat Patients Who Mobilize Hematopoietic Stem Cells Poorly
- A Randomized Study Comparing Filgrastim Versus Lenograstim Versus Molgramostim Plus Chemotherapy for Peripheral Blood Progenitor
- Mitigative Efficacy of the Clinical Dosage Administration Of
- BQC19 Core Analyses Table of Contents
- Lonquex, INN-Lipegfilgrastim
- REVIEW Role of Cytokines in the Treatment of Acute Leukemias
- The Incidence and Clinical Features of Pegylated Filgrastim-Induced Acute
- Efficacy and Safety Analysis of Once Per Cycle Pegfilgrastim and Daily
- A Novel Sponge-Derived Protein Thrombocorticin Is a New Agonist for Thrombopoietin Receptor
- Kinase Inhibitors and Monoclonal Antibodies in Oncology: Clinical Implications
- Pharmacokinetics and Adverse Events Following 5-Day Repeated
- Colony Stimulating Factors
- Which One Is More Effective, Filgrastim Or Lenograstim, During
- HEMATOPOIETIC AGENTS;GROWTH FACTORS,MINERALS and VITAMINS Phr.Volkan KAHRAMAN HGF’S
- Improving Access to Cancer Care a First Analysis of Pharmaceutical Company Actions in Low- and Middle-Income Countries
- Product Information for Auspar Lonquex Lipegfilgrastim (Rbe) Teva Pharma Australia Pty Ltd, PM- 2014-03142-1-4 Final 23 February 2016
- Lonquex, INN-Lipegfilgrastim
- Thrombopoietin a Preclinical Evaluation
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Association Between Acute Myelogenous Leukemia and Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia
- Lipegfilgrastim in the Management of Chemotherapy-Induced Neutropenia of Cancer Patients
- 3.2.2 Granulocyte-Colony Stimulating Factors, Pulmonary Haemorrhage
- Novel Agents and Approaches for Stem Cell Mobilization in Normal Donors and Patients
- White Blood Cell Colony Stimulating Factors – Commercial Medical Benefit Drug Policy
- Original Article a Comparative Analysis Between Pegfilgrastim And
- The Efficacy of Recombinant Thrombopoietin in Murine and Nonhuman Primate Models for Radiation-Induced Myelosuppression and Stem Cell Transplantation
- Soft Tissue Sarcoma